Ctt Pharmaceutical Holdings Stock Investor Sentiment

CTTH Stock  USD 0.06  0  6.19%   
Under 62% of CTT Pharmaceutical's investor base is looking to short. The analysis of overall sentiment of trading CTT Pharmaceutical Holdings pink sheet suggests that many investors are alarmed at this time. CTT Pharmaceutical's investing sentiment shows overall attitude of investors towards CTT Pharmaceutical Holdings.
  
over three months ago at news.google.com         
Allied gaming executive Choi buys shares worth 778k By Investing.com - Investing.com Canada
Google News at Macroaxis
over three months ago at news.google.com         
CTT Pharmaceutical CEO acquires 78 worth of company stock By Investing.com - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
CTT Pharmaceutical Holdings CEO buys 70 in company stock By Investing.com - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
CTT Pharmaceutical Holdings CEO buys 98 in company stock By Investing.com - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
Ctt Pharmaceutical Holdings CEO buys shares worth 147 By Investing.com - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
Why Cettire, Neuren, Peter Warren, and Qantas shares are falling today - The Motley Fool Australia
Google News at Macroaxis
over six months ago at news.google.com         
CTT Pharmaceutical CEO acquires shares worth 84 By Investing.com - Investing.com Canada
Google News at Macroaxis
over six months ago at news.google.com         
CTT Pharmaceutical Holdings CEO acquires 380 in shares By Investing.com - Investing.com
Google News at Macroaxis
over six months ago at news.google.com         
18 Share Tips 8th April 2024 - TheBull.com.au
Google News at Macroaxis
over six months ago at news.google.com         
CTT Pharma Partners with Johns Hopkins University for NIH Grant for a Smoking Cessation Product - Ma...
Google News at Macroaxis
over a year ago at news.google.com         
Exploring targeted preventive health check interventions a realist ... - BMC Public Health
Google News at Macroaxis
over a year ago at news.google.com         
Bell Potter says these are the best ASX shares to buy in October - The Motley Fool Australia
Google News at Macroaxis
over a year ago at news.google.com         
ASX rebalance Time to go, Harvey Norman - Toowoomba Chronicle
Google News at Macroaxis
over a year ago at news.google.com         
Cettire founder sells 100m worth of stock - Business News Australia
Google News at Macroaxis
over a year ago at news.google.com         
Telaprevir Treatment Reduces Paralysis in a Mouse Model of ... - American Society for Microbiology
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about CTT Pharmaceutical that are available to investors today. That information is available publicly through CTT media outlets and privately through word of mouth or via CTT internal channels. However, regardless of the origin, that massive amount of CTT data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of CTT Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of CTT Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to CTT Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive CTT Pharmaceutical alpha.

CTT Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for CTT Pink Sheet analysis

When running CTT Pharmaceutical's price analysis, check to measure CTT Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CTT Pharmaceutical is operating at the current time. Most of CTT Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of CTT Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CTT Pharmaceutical's price. Additionally, you may evaluate how the addition of CTT Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios